Jan 12 (Reuters) - Integral Diagnostics Ltd:
* ‍CAPITAL EXPENDITURE FOR FULL YEAR IS FORECAST AT $17M​ * EXPECTS ACHIEVEMENT OF FULL YEAR NORMALISED NPAT GROWTH OF AROUND 20% (BEFORE TAKEOVER RESPONSE COSTS AND TRANSACTION COSTS) Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.